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Embryonic stem (ES) cells potently repress retroviral
infection through transcriptional silencing of the newly
established proviral DNAs. We have characterized two
distinct types of silencing in embryonic mouse cells
infected by the Moloney murine leukemia virus (MLV): a
highly efficient one targeted to the proline tRNA primer
binding site (PBSpro) on the MLV genome, and a less
efficient one occurring independently of the PBS. We
determined that the PBS-specific silencing is mediated by
TRIM28 (Kap-1), a known transcriptional silencer, teth-
ered to the DNA by ZFP809, one of the dozens of zinc
finger proteins encoded in the mammalian genome. At
least two more components, HP1gamma and EBP1, are
implicated in this silencing. We have also begun charac-
terizing a non-PBS directed silencing complex acting
more broadly on incoming viral DNAs in ES cells. We
suggest that a major player in this process is Yin Yang1
(YY1), a GLI-Kruppel zinc finger protein, ubiquitously
expressed and highly conserved between species. We
show by ChIP that YY1 binds the LTR of both exogenous
and endogenous retroviruses in ES cells. Deletion of the
YY1 binding site from the MLV-LTR increased expres-
sion of the provirus at least four fold over that of the
wild-type virus. Moreover, in YY1 KD cells the expres-
sion of the IAP (class II) endogenous retroviruses was
remarkably upregulated.
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